SEDA-Q
Dead / Abandoned — Abandoned — failure to respond (as of 04 Jan 2022)
What this means for you
This application is over — abandoned 27 Dec 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88939015
- Mark type
- Stylized text
- Filed
- 29 May 2020
- Published for opposition
- 13 Oct 2020
- Abandoned
- 27 Dec 2021
- Attorney of record
- Thomas W. Galvani
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations for the treatment of medical disorders treatable by parenteral infusion therapy, namely, pain, cancer, infectious diseases, bacterial diseases, autoimmune diseases, cardiovascular diseases, fungal diseases, and metabolic diseases and for induction and maintenance of anesthesia; Sterile preparations for medical purposes in clinical treatment for treating pain, cancer, infectious diseases, bacterial diseases, autoimmune diseases, cardiovascular diseases, fungal diseases and metabolic diseases and for induction and maintenance of anesthesia; Medicinal preparations for pharmaceutical purposes for treating pain, cancer, infectious diseases, bacterial diseases, autoimmune diseases, cardiovascular diseases, fungal diseases and metabolic diseases and for induction and maintenance of anesthesia; Drug delivery agents in the form of pharmaceutical infusion pumps that facilitate the delivery of pharmaceutical preparations; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations
- Class 010 — Medical apparatus: Surgical apparatus and instruments for medical, dental and veterinary use for performing parenteral infusions in the field of medical and surgical procedures; Medical devices, namely, parenteral infusion pumps and dispensers for delivering measured amounts of solutions into the bloodstream over time; Medical infusion pumps for delivering measured amounts of solutions into the bloodstream over time
Owner
- MADRYN BIOQ SPV, LLC, NEW YORK, NY, US
- BioQ Pharma, Inc., San Francisco, CA, US
- BioQ Pharma, Inc., San Francisco, CA, US
Prosecution history
- 09 Sept 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 04 Jan 2022 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 04 Jan 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 23 Jun 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Jun 2021 — NON-FINAL ACTION E-MAILED
- 23 Jun 2021 — SU - NON-FINAL ACTION - WRITTEN
- 21 May 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 12 May 2021 — USE AMENDMENT FILED
- 21 May 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 May 2021 — TEAS STATEMENT OF USE RECEIVED
- 08 Dec 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Oct 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Oct 2020 — PUBLISHED FOR OPPOSITION
- 23 Sept 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Sept 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER